Lyell Immunopharma(LYEL)
$13.80+0.22 (+1.62%)
LYEL
Lyell Immunopharma hedge funds
$13.80
At close:+0.22 (+1.62%)
Want to see LYEL full AI Analyst Report?
Lyell Immunopharma (LYEL) Hedge Fund Trading Activity
163 Followers
Trend: ▲ Hedge Funds Increased Holdings by 563.5K Shares Last Quarter
Hedge Fund Holdings in LYEL
Based on the 13F filings of 489 Hedge Funds tracked by TipRanks, as submitted to the SEC.
Hedge Fund Confidence Signal
Hedge Fund Activity
Activity
Star Ranking
| Added | 10.31% | $7,822,768 | <0.01% | ||||
| EntryPoint Capital, LLC | Sold Out | -100.00% | $0 | 0.00% | |||
| Graham Capital Management, L.P. | Sold Out | -100.00% | $0 | 0.00% |
FAQ
Which hedge funds hold Lyell Immunopharma?
The hedge funds that hold the most shares in Lyell Immunopharma are BlackRock, Inc., Andrew Alkon and Kenneth Tropin.
Are hedge funds buying or selling LYEL?
In the last quarter hedge funds have Increased their holdings in Lyell Immunopharma by 563.5K shares.
Where can I see a list of the best rated hedge funds?
You can see a list of the best hedge funds here.
Who is the best-performing hedge fund manager?
The top-rated hedge fund managers can be seen here: Top Hedge Fund Managers
Does Warren Buffet hold shares in Lyell Immunopharma stock?
Warren Buffet currently does not own shares in Lyell Immunopharma.
What is a 13F filing, and how does it help investors?
A 13F form, also known as a "Report of Investment Manager," is a quarterly report that investment advisors registered with the Securities and Exchange Commission (SEC) must file if they manage at least $100 million in assets. The 13F form lists all of the publicly traded securities that the investment advisor owns as of the end of the reporting period. To read more about the 13F, click here

